Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideki Goto

Showing results (51-60 of 95) with videos related to

Pageof 10
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 22, 2020
Current Status and Needs of Long-Term Follow-Up Clinics for Hematopoietic Cell Transplantation Survivors: Results of a Nationwide Survey in JapanSaiko Kurosawa, Ayako Mori, Mayumi Tsukagoshi, et al.
Internal Medicine (Tokyo, Japan)|April 23, 2026
A Case of Acute Myeloid Leukemia with MOZ::TIF2 Fusion Gene Resulting from a Novel BreakpointToma Suzuki, Masahiro Onozawa, Minoru Kanaya, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 18, 2018
Hematogones Predict Better Outcome in Allogeneic Hematopoietic Stem Cell Transplantation Irrespective of Graft SourcesTakashi Ishio, Junichi Sugita, Takahiro Tateno, et al.
The Journal of Investigative Dermatology|May 6, 2019
Cultured Epidermal Autografts from Clinically Revertant Skin as a Potential Wound Treatment for Recessive Dystrophic Epidermolysis BullosaWakana Matsumura, Yasuyuki Fujita, Satoru Shinkuma, et al.
Cancer Science|September 2, 2022
Ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma: CARTITUDE-1 (phase 2) Japanese cohortMasaki Ri, Kenshi Suzuki, Tadao Ishida, et al.
Cytotherapy|March 29, 2025
Center effect on outcomes of second allogeneic hematopoietic stem cell transplantation for B-cell acute lymphoblastic leukemia: a nationwide retrospective studyShuhei Kurosawa, Takahiro Fukuda, Tatsuo Ichinohe, et al.
International Journal of Clinical Oncology|April 18, 2023
Safety and efficacy of tisagenlecleucel in patients with relapsed or refractory B-cell lymphoma: the first real-world evidence in JapanHideki Goto, Toshio Kitawaki, Nobuharu Fujii, et al.
Transplantation and Cellular Therapy|November 8, 2025
Safety and Efficacy of Graft-versus-Host Disease Prophylaxis with Mini-Dose Methotrexate in Umbilical Cord Blood Transplantation: An NJHSG-CBT18 Observational StudySouichi Shiratori, Keito Suto, Yuta Hasegawa, et al.
British Journal of Haematology|January 8, 2025
A phase II study of zandelisib in patients with relapsed or refractory indolent non-Hodgkin lymphoma: ME-401-K02 studyWataru Munakata, Takahiro Kumode, Hideki Goto, et al.
International Journal of Hematology|September 1, 2011
Sequential chemotherapy and myeloablative allogeneic hematopoietic stem cell transplantation for refractory acute lymphoblastic leukemiaKotaro Arita, Takeshi Kondo, Junichi Sugita, et al.
Pageof 10

Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 22, 2020
Current Status and Needs of Long-Term Follow-Up Clinics for Hematopoietic Cell Transplantation Survivors: Results of a Nationwide Survey in JapanSaiko Kurosawa, Ayako Mori, Mayumi Tsukagoshi, et al.
Internal Medicine (Tokyo, Japan)|April 23, 2026
A Case of Acute Myeloid Leukemia with MOZ::TIF2 Fusion Gene Resulting from a Novel BreakpointToma Suzuki, Masahiro Onozawa, Minoru Kanaya, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 18, 2018
Hematogones Predict Better Outcome in Allogeneic Hematopoietic Stem Cell Transplantation Irrespective of Graft SourcesTakashi Ishio, Junichi Sugita, Takahiro Tateno, et al.
The Journal of Investigative Dermatology|May 6, 2019
Cultured Epidermal Autografts from Clinically Revertant Skin as a Potential Wound Treatment for Recessive Dystrophic Epidermolysis BullosaWakana Matsumura, Yasuyuki Fujita, Satoru Shinkuma, et al.
Cancer Science|September 2, 2022
Ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma: CARTITUDE-1 (phase 2) Japanese cohortMasaki Ri, Kenshi Suzuki, Tadao Ishida, et al.
Cytotherapy|March 29, 2025
Center effect on outcomes of second allogeneic hematopoietic stem cell transplantation for B-cell acute lymphoblastic leukemia: a nationwide retrospective studyShuhei Kurosawa, Takahiro Fukuda, Tatsuo Ichinohe, et al.
International Journal of Clinical Oncology|April 18, 2023
Safety and efficacy of tisagenlecleucel in patients with relapsed or refractory B-cell lymphoma: the first real-world evidence in JapanHideki Goto, Toshio Kitawaki, Nobuharu Fujii, et al.
Transplantation and Cellular Therapy|November 8, 2025
Safety and Efficacy of Graft-versus-Host Disease Prophylaxis with Mini-Dose Methotrexate in Umbilical Cord Blood Transplantation: An NJHSG-CBT18 Observational StudySouichi Shiratori, Keito Suto, Yuta Hasegawa, et al.
British Journal of Haematology|January 8, 2025
A phase II study of zandelisib in patients with relapsed or refractory indolent non-Hodgkin lymphoma: ME-401-K02 studyWataru Munakata, Takahiro Kumode, Hideki Goto, et al.
International Journal of Hematology|September 1, 2011
Sequential chemotherapy and myeloablative allogeneic hematopoietic stem cell transplantation for refractory acute lymphoblastic leukemiaKotaro Arita, Takeshi Kondo, Junichi Sugita, et al.
Pageof 10